You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

thrombopoietin receptor agonist (TPO-RA)

Showing 1 - 25 of 9,904
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Ianalumab
  • (no location specified)
Jun 5, 2023

Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

Not yet recruiting
  • Poor Graft Function
  • (no location specified)
Dec 29, 2022

Stem Cell Transplant Complications Trial in Suzhou (Eltrombopag 25 MG Oral Tablet, Thrombopoietin)

Not yet recruiting
  • Stem Cell Transplant Complications
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jul 17, 2022

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

    Recruiting
    • Aplastic Anemia
    • +2 more
    • Beijing, China
      Peking union medical college hospital
    Aug 20, 2023

    MDS, Thrombocytopenia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

    Completed
    Has Results
    • Myelodysplastic Syndromes
    • Thrombocytopenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 8, 2022

    Moderate Aplastic Anemia, Unilineage Bone Marrow Failure Disorders Trial run by the NHLBI (Eltrombopag)

    Active, not recruiting
    Has Results
    • Moderate Aplastic Anemia
    • Unilineage Bone Marrow Failure Disorders
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 2, 2021

    Tumor Therapy-related Thrombocytopenia Trial (TPO-RA (Herombopag), TPO-RA (Herombopag) and rhTPO(Recombinant human

    Not yet recruiting
    • Tumor Therapy-related Thrombocytopenia
    • TPO-RA (Herombopag)
    • TPO-RA (Herombopag) and rhTPO(Recombinant human thrombopoietin)
    • (no location specified)
    Apr 27, 2022

    Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

    Recruiting
    • Autoimmune Hemolytic Anemia
    • +5 more
    • cytokine essays
    • +6 more
    • Milano, Italy
      Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
    Jul 3, 2023

    Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Jun 8, 2023

    Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • eltrombopag and romiplastim
    • (no location specified)
    Nov 16, 2023

    Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):

    Recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Eltrombopag (Revolade®)
    • standard therapy (without eltrombopag): HD-DXM
    • Aarau, Switzerland
    • +5 more
    Sep 5, 2022

    Anemia, Aplastic, Anemia, Hypoplastic, Thrombocytopenia Trial run by the NHLBI (Eltrombopag)

    Completed
    Has Results
    • Anemia, Aplastic
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Sep 30, 2020

    Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)

    Recruiting
    • Diabetes Mellitus
    • Diabetic Kidney Disease
    • Sha Tin, Hong Kong
      Prince of Wales Hospital
    Nov 8, 2022

    Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

    Not yet recruiting
    • Obesity
    • +16 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Nov 14, 2023

    Breast Cancer Trial in Zhengzhou (Hetrombopag, rh-TPO)

    Not yet recruiting
    • Breast Cancer
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    May 26, 2022

    Immune Thrombocytopenia Trial in Switzerland (romiplostim)

    Completed
    • Immune Thrombocytopenia
    • Liestal, Basel-Land, Switzerland
    • +4 more
    May 6, 2020

    Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

    Recruiting
    • Hematological Disease
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Feb 6, 2023

    Persistent or Chronic ITP Trial in Creteil (Tpo-RA discontinuation)

    Unknown status
    • Persistent or Chronic ITP
    • Tpo-RA discontinuation
    • Creteil, France
      Henri-Mondor Hospital
    Feb 17, 2020

    Type 2 Diabetes Trial in Copenhagen (Endurance exercise training, Semaglutide)

    Recruiting
    • Type 2 Diabetes
    • Copenhagen, Denmark
      Xlab, Center for Healthy Aging, Department of Biomedical Science
    Feb 8, 2021

    Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)

    Not yet recruiting
    • Aplastic Anemia
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching

    Not yet recruiting
    • Gastrointestinal Cancer
    • +2 more
    • Miami, Florida
    • +1 more
    Mar 6, 2023

    Immune Thrombocytopenia, Treatment Trial in Tianjin (CM313 Injection)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Treatment
    • CM313 Injection
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Jan 12, 2023

    Antiphospholipid Syndrome, Thrombocytopenia Trial in Tianjin (Anti-CD38 antibody Injection)

    Recruiting
    • Antiphospholipid Syndrome
    • Thrombocytopenia
    • Anti-CD38 antibody Injection
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Aug 9, 2023

    Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic, Glucocorticoids Trial in Fuzhou (rapid GCs taper)

    Enrolling by invitation
    • Lupus Erythematosus, Systemic
    • +3 more
    • rapid GCs taper
    • Fuzhou, Fujian, China
      Fujian Medical University Union Hospital
    Aug 16, 2022